Microtubule Instability
Microtubule Instability
Intracellular Signaling Affects Focal Adhesions
Destabilization of Microtubules
M-Cdk Drives Transition Into Mitosis
PI3K/mTOR/AKT Signaling Pathway
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

Simultaneous Visualization of the Dynamics of Crosslinked and Single Microtubules In Vitro by TIRF Microscopy
Published on: February 18, 2022
Simin Lim1, Eiko Kawamura, Andrew B Fielding
1Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
This study explores how integrin-linked kinase (ILK) affects microtubule dynamics in HeLa cells, a type of cancer cell. ILK is known to regulate cell adhesion and centrosome function, but its role in microtubule behavior was unclear. The researchers found that overexpressing ILK in HeLa cells led to shorter mitotic durations and reduced sensitivity to paclitaxel, a drug that stabilizes microtubules. This suggests that ILK may destabilize microtubules during interphase. When the researchers used QLT-0267, an ILK inhibitor, they observed suppressed microtubule dynamics and increased inter-centromere tension during mitosis. These findings indicate that ILK modulates microtubule stability in both interphase and mitotic cells. The study provides new insights into how ILK influences microtubule dynamics and may inform future cancer treatment strategies.
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
10:25High-resolution Time-lapse Imaging and Automated Analysis of Microtubule Dynamics in Living Human Umbilical Vein Endothelial Cells
Published on: August 13, 2016
Area of Science:
Background:
Microtubules undergo dynamic changes during the cell cycle, especially during interphase and mitosis. These structures are essential for chromosome segregation and cell division. Prior research has shown that integrin-linked kinase (ILK) influences focal adhesion and centrosome functions. However, the role of ILK in regulating microtubule dynamics remains unclear. While ILK is known to affect cell adhesion and migration, its impact on microtubule behavior in mitotic cells has not been fully explored. This uncertainty has motivated investigations into how ILK might modulate microtubule stability. No prior work had resolved whether ILK promotes or suppresses microtubule dynamics during interphase or mitosis. Understanding this could reveal new therapeutic strategies. The gap in knowledge has driven recent studies to explore ILK’s role in microtubule regulation. This paper addresses that gap by examining ILK's effects on microtubule dynamics in cancer cells.
Purpose Of The Study:
The study aimed to determine how integrin-linked kinase (ILK) affects microtubule dynamics in both interphase and mitotic cells. Researchers focused on HeLa cells, a commonly used cancer cell line, to investigate the consequences of ILK overexpression. The motivation stemmed from the observation that elevated ILK levels are often found in various cancers. The goal was to clarify whether ILK influences microtubule stability and how that might affect cancer cell behavior. The researchers sought to understand if ILK could alter sensitivity to chemotherapeutic agents like paclitaxel. They also wanted to explore the effects of ILK inhibition on microtubule dynamics. The study aimed to provide mechanistic insights into ILK’s dual role as a kinase and scaffolding protein. By examining microtubule dynamics, the researchers hoped to uncover new therapeutic possibilities.
Main Methods:
The researchers used HeLa cells to overexpress integrin-linked kinase (ILK) and then measured microtubule dynamics during interphase and mitosis. They also applied QLT-0267, a selective ILK inhibitor, to assess its impact on microtubule behavior. Microtubule dynamics were analyzed using fluorescence microscopy and live-cell imaging techniques. The duration of mitosis was tracked using time-lapse imaging to observe changes in cell division. Sensitivity to paclitaxel was evaluated by measuring cell survival after drug exposure. Cold depolymerization experiments were conducted to assess microtubule regrowth rates. Chromosome alignment and inter-centromere tension were monitored during mitosis to evaluate spindle stability. The study combined biochemical assays with functional imaging to dissect ILK’s role in microtubule regulation.
Main Results:
Overexpression of integrin-linked kinase (ILK) in HeLa cells was associated with a shorter mitotic duration and reduced sensitivity to paclitaxel. ILK overexpression favored microtubule depolymerization during interphase, suggesting a destabilizing effect on microtubules. Paclitaxel typically stabilizes microtubules, and ILK overexpression may counteract this effect. The use of QLT-0267, an ILK inhibitor, suppressed microtubule dynamics, indicating a new mechanism for this compound. QLT-0267 treatment increased inter-centromere tension in aligned chromosomes during mitosis. Cold depolymerization experiments showed slower microtubule regrowth in ILK-inhibited cells. Spindle microtubules in treated cells appeared more stable than in controls. These findings suggest that ILK modulates microtubule dynamics in both interphase and mitotic stages.
Conclusions:
The study concludes that integrin-linked kinase (ILK) influences microtubule dynamics in both interphase and mitotic cells. ILK overexpression was associated with shorter mitotic durations and reduced paclitaxel sensitivity. These effects suggest that ILK may destabilize microtubules during interphase. The use of QLT-0267 demonstrated that ILK inhibition can suppress microtubule dynamics. Treated cells showed increased inter-centromere tension and slower microtubule regrowth. Spindle microtubules became more stable in the presence of the ILK inhibitor. The findings support the idea that ILK regulates microtubule stability during cell division. The authors propose that ILK’s dual role as a kinase and scaffolding protein contributes to these effects.
ILK overexpression in HeLa cells was associated with microtubule depolymerization and reduced sensitivity to paclitaxel.
QLT-0267 is an ILK inhibitor that suppressed microtubule dynamics and increased inter-centromere tension in mitotic cells.
HeLa cells are a well-characterized cancer cell line, making them suitable for studying microtubule dynamics and drug responses.
ILK overexpression was associated with a shorter duration of mitosis in HeLa cells.
Cold depolymerization experiments were used to assess microtubule regrowth after ILK inhibition.
The results suggest that ILK may influence microtubule stability and could affect responses to chemotherapeutic agents like paclitaxel.